BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31873917)

  • 1. Utility of PET/CT in patients with stage I-III melanoma.
    Avilés Izquierdo JA; Molina López I; Sobrini Morillo P; Márquez Rodas I; Mercader Cidoncha E
    Clin Transl Oncol; 2020 Aug; 22(8):1414-1417. PubMed ID: 31873917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
    Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of lymph node ultrasound and whole body
    Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
    Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trial.
    Stoffels I; Herrmann K; Rekowski J; Jansen P; Schadendorf D; Stang A; Klode J
    Trials; 2019 Feb; 20(1):99. PubMed ID: 30717811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
    Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
    Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
    Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
    Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-CT for staging pT4b melanomas prior to sentinel lymph node biopsy: a 5-year review.
    Hardie CM; Allouni A; Edwards S; Ahmed N; Maraveyas A; Matteucci PL
    Melanoma Res; 2021 Aug; 31(4):397-401. PubMed ID: 34039943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Kwak JJ; Kesner AL; Gleisner A; Jensen A; Friedman C; McCarter MD; Koo PJ; Morgan RL; Kounalakis N
    Ann Surg Oncol; 2020 May; 27(5):1432-1438. PubMed ID: 31773513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of clinical impact of
    Liu J; Larcos G; Howle J; Veness M
    Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of initial CT staging before sentinel lymph node biopsy in patients with head and neck cutaneous melanoma.
    Hafström A; Silfverschiöld M; Persson SS; Kanne M; Ingvar C; Wahlberg P; Romell A; Greiff L
    Head Neck; 2017 Nov; 39(11):2301-2310. PubMed ID: 28833785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
    Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H
    Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
    Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
    Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging patients with cutaneous malignant melanoma by same-day lymphoscintigraphy and sentinel lymph node biopsy: a single-institutional experience with emphasis on recurrence.
    Gad D; Høilund-Carlsen PF; Bartram P; Clemmensen O; Bischoff-Mikkelsen M
    J Surg Oncol; 2006 Aug; 94(2):94-100. PubMed ID: 16847917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
    Constantinidou A; Hofman M; O'Doherty M; Acland KM; Healy C; Harries M
    Melanoma Res; 2008 Feb; 18(1):56-60. PubMed ID: 18227709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging.
    Gjorup CA; Woodford R; Li I; Carlino MS; Ch'ng S; Chung D; Hsiao E; Lo SN; London K; Long GV; Menzies AM; Nieweg OE; Pennington TE; Rtshiladze MA; Saw RPM; Scolyer RA; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Varey AHR; van Akkooi ACJ
    Ann Surg Oncol; 2024 Mar; 31(3):1857-1864. PubMed ID: 37966706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
    Helvind NM; Aros Mardones CA; Hölmich LR; Hendel HW; Bidstrup PE; Sørensen JA; Chakera AH
    Eur J Surg Oncol; 2021 Dec; 47(12):3020-3027. PubMed ID: 34120809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.